Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN952891 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-IMP3, U3 Small Nucleolar Ribonucleoprotein, Homolog (Yeast) (IMP3) (AA 155-184), (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Protein A column, followed by peptide affinity purification
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 155-184, C-Term
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas.
IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.
IMP3 expression in human ovarian cancer is associated with improved survival.
IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
Riener MO, Fritzsche FR, Clavien PA, Pestalozzi BC, Probst-Hensch N, Jochum W, Kristiansen G
Human pathology 2009 Oct;40(10):1377-83
Human pathology 2009 Oct;40(10):1377-83
IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.
Walter O, Prasad M, Lu S, Quinlan RM, Edmiston KL, Khan A
Human pathology 2009 Nov;40(11):1528-33
Human pathology 2009 Nov;40(11):1528-33
IMP3 expression in human ovarian cancer is associated with improved survival.
Noske A, Faggad A, Wirtz R, Darb-Esfahani S, Sehouli J, Sinn B, Nielsen FC, Weichert W, Buckendahl AC, Röske A, Müller B, Dietel M, Denkert C
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2009 May;28(3):203-10
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2009 May;28(3):203-10
IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
Li D, Yan D, Tang H, Zhou C, Fan J, Li S, Wang X, Xia J, Huang F, Qiu G, Peng Z
Annals of surgical oncology 2009 Dec;16(12):3499-506
Annals of surgical oncology 2009 Dec;16(12):3499-506
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS
